Currently, he is the Deputy Director of the Department of Gynecological Endocrinology and Reproductive Medicine, The Obstetrics and Gynecology Hospital of Fudan University, the Deputy Chairman of the Youth Committee of the Gynecology Branch of the Chinese Geriatrics Society, the Deputy Chairman of the Youth Committee of the Gynecology Branch of the Chinese Gerontology and Gerontology Society, and the member of the Endocrinology Group of the Gynecology Branch. Member of reproductive Endocrinology Professional Committee of China Medical Education Association, standing member of Menopause Training Center of Reproductive Endocrinology Professional Committee, member of Osteoporosis branch of Shanghai Medical Association, member of Scientific Popularization Branch of Shanghai Medical Doctor Association, member of National Health Science Popularization expert Bank.

Expertise
Minimally invasive treatment of gynecological benign and malignant tumors, including single-port and traditional laparoscopic surgery for uterine fibroids, ovarian cysts, cervical cancer and infertility. Diagnosis and treatment of diseases related to abnormal ovarian function, including polycystic ovary syndrome, premature ovarian failure, menopausal syndrome and menstrual disorders

Dr. Vic YAO currently serves as a Critical Care Medicine specialist in Jiahui International Hospital. Dr. Yao obtained his Doctor degree from Capital Medical University in 2012. From 2012 to 2022, he worded in the Department of critical care medicine of Shandong provincial hospital and completed the standardized training of critical care medicine residents and the standardized training of critical care medicine specialty, until he promoted to deputy chief physician. During this period, he participated in the compilation of two books Neurocritical Care and Practical Clinical Monitoring and Treatment of Acute and Critical Diseases, published 5 articles in Chinese or English core journals, and served as teaching or teaching tasks in National and Provincial critical care bronchoscopy and critical care ultrasound classes for many times, in the meanwhile he served as the secretary of Shandong Critical Care Medicine Quality Control Center. In 2022, Dr. Yao joined Jiahui as a member of the HDU team. Based on clinical front-line work experience and knowledge accumulation, Dr. Yao is familiar with theories and technologies related to intensive care and treatment, including ECMO, CRRT, critical bronchoscopy diagnosis and treatment technology, bedside critical ultrasound technology, hemodynamic monitoring technology, endotracheal intubation and mechanical ventilation, etc. He has dedicated his work to apply advanced critical care medicine related diagnosis and treatment technology to treat critically ill patients in an all-round way.

Dr. Yao is certified in Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS) by American Heart Association (AHA), and the 5C Critical Care Specialist Qualification Certificate issued by the Critical Care Medicine Branch of the Chinese Medical Association.

Dr. Ferris LI is currently the Deputy Chief of Intensive Care Unit (ICU) in JiaHui International Hospital. Dr. Li obtained his Bachelor’s Degree of Clinical Medicine in 2002 and Master’s Degree of Cardiovascular Surgery in 2010 from Shanghai Jiaotong University School of Medicine. He obtained Doctorate Degree in 2022. Before joining Jiahui Health, Dr. Li worked in Shanghai Chest hospital for 18 years and completed residency in intensive care unit in that hospital. In 2012 and 2018, he completed the promotion of attending physician and deputy chief physician. During 2009 to 2021, Dr. Li published 13 articles in core journals, obtained one utility model patent led and participated two projects from National Natural Science Foundation of China, participated in the book of thoracic surgery and served on Critical Care Specialist of Shanghai Medical Association and Critical Care Specialist of Shanghai traditional Chinese Medicine Association. In 2021, Dr. Li joined Jiahui as a member of the HDU team. Dr. Li has mastered the theory and technology of critical care medicine, including perioperative management of cardiothoracic surgery, postoperative complication management and functional rehabilitation, and is responsible for the “three-basic” examination and Cardiopulmonary Resuscitation （CPR）training of the whole hospital.

Dr. Li is certified in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) by American Heart Association (AHA).

Dr. ZHENG Xiaohong graduated from Kunming Medical University with a master's degree in oral and maxillofacial surgery. I have completed the standardized training for resident doctors in Yunnan Provincial Stomatological Hospital.I am good at kinds of impacted teeth, complex teeth and multiple teeth extraction, oral and maxillofacial mass excision, curettage of jaw cyst, vascular and lymphangioma diagnosis and treatment,maxillofacial space infection incision drainage, tooth defect filling treatment and periodontal basic treatment. 

Dr. Yiqun YAN, is a multi-practitioner of Jiahui Health, former chief physician, professor (2001) and doctoral supervisor (2003) of the Eastern Hepatobiliary Surgery Hospital Affiliated to the Second Military Medical University of the Navy.
From 1997.3 to 2000.3， he had studied clinical liver transplantation at Royal Prince Alver Hospital (RPA), Australia National Liver Transplant Center. He was a temporary registered transplant surgeon in New South Wales for 3 years and completed postdoctoral research at the Centenary Cancer Institute, University of Sydney. His research results were published in the Journal of Immunology and Transplantation.
Graduated from the Department of Military Medicine of the Fourth Military Medical University in 1984, that is, with the guidance of Academician Wu Mengchao, a famous expert in hepatobiliary surgery in China, he has been engaged in the clinical practice of hepatobiliary surgery for 40 years, and has completed a total of more than 5,500 cases of liver, biliary, pancreatic and splenic operations. Liver transplantation has been carried out earlier in China, and intratumor injection of anhydroalcohol before surgery has prevented the recurrence of liver cancer after surgery. In vivo gamma knife treatment of liver cancer (radioactive particle implantation), multiple hepatectomy for the treatment of intrahepatic and external bile duct stones, the evaluation of prealbumin and liver function impairment and liver reserve function, hepatectomy plus fenestrated drainage for adult polycystic liver disease, etc., all achieved good results. In recent years, his studies on the standard treatment of hepatocellular carcinoma with portal hypertension, standard treatment of BCLC stage B hepatocellular carcinoma, perioperative antiviral therapy of hepatocellular carcinoma, long-term clinical observation of hepatic hemangioma, and comprehensive treatment strategies for recurrent liver cancer have been carried out and published.
Since 2001, he has published more than 80 papers in academic journals at home and abroad, including more than 40 papers in international journals, edited 1 monograph "Liver Tumor Surgery Technique Image Diagram" (Shanghai Science and Technology Education Press, 2009), participated in the compilation of 11 books. He won 1 second prize of National Science and Technology Progress, 3 third prizes of military medical achievements, 1 second prize and 1 third prize of Chinese Medical Association of Young and middle-aged excellent papers of the Ministry of Health, and SOMPS Award at the 14th International Anti-Cancer Conference (Paris, France)

Dr. BAI serves as a family medicine physician at Jiahui Health. He graduated from Qiqihar Medical University, earning a Bachelor of Clinical Medicine degree, and holds a certificate of completion for the National Standardized Resident Training.With over seven years of clinical experience, Dr. Bai is proficient in diagnosing and treating common internal and surgical conditions, handling emergency situations, and managing chronic diseases. He also holds certifications in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) from the American Heart Association.

Driven by a patient - centered philosophy, Dr. BAI listens attentively to patients' concerns. With his professional capabilities and caring attitude, he is committed to safeguarding patients' health.

YUAN Yifei, PhD, Deputy chief physician of the Eye&ENT Hospital Affiliated to Fudan University.

Specialties:
● Orbital diseases, such as orbital tumors, orbital fractures, orbital foreign bodies, thyroid related eye diseases, naso-eye related diseases, optic nerve trauma;
● Eyelid diseases, such as eyelid masses (benign and malignant tumors, hordeolum, chalazia), entropion, trichiasis, ectropion, ptosis, eyelid retraction;
● Diseases of the lacrimal passage, such as obstructive diseases of the lacrimal passage and chronic dacryocystitis, obstruction of the lacrimal passage in children, lacrimal passage trauma and artificial lacrimal duct implantation, and lacrimal passage tumors;
● Socket and prosthetic eye related, such as prosthetic eye implantation, conjunctival sac stenosis and reconstruction, treatment of prosthetic eye related eyelid problems
● Ocular surface masses, such as horn conjunctival masses, blepharon adhesions, etc

Dr. LIU Yan is currently a pediatrician at Jiahui Health. Dr Liu graduated from Shanghai Jiaotong University School of Medicine with a master's degree in 2019. After graduation, she worked in Shanghai Children's Medical Center, mainly undertaking clinical work in pediatric internal medicine. She specialises in the diagnosis and treatment of all types of common and frequent diseases in children.

She holds certifications in Basic Life Support (BLS) for Children and Pediatric Advanced Life Support (PALS).

Dr. Feng Rui is currently a multi-practitioner of Jiahui Health, and he is chief physician and doctoral supervisor. He has rich experience in endovascular treatment of high difficulty diseases. He is the director of the vascular surgery Department of the Intervention Center of Shanghai First People's Hospital and has won the title of the first National Famous Doctor in 2017, and ranked the first in the vascular surgery department of China's Good Doctors from 2020 to 2024. For a long time, he has focused on endovascular minimally invasive treatment of various vascular diseases, and is one of the most difficult aortic minimally invasive treatment surgeons in China with the larg est number of cases. He has been more than 200 large hospitals in 28 provinces across the country to guide complex operations, and earned a high reputation in the industry. He is currently the deputy chairman and director general of the Chinese Medical Doctor Association Endovascular Committee, the deputy chairman of the aortic dissection Group of the Chinese Medical Doctor Association, and the head of the Shanghai Aortic disease Clinical database. He has won the second prize of the National Science and Technology Progress Award and the first prize of the Chinese Medical Science and Technology Award, and presided over two National Natural Fund projects and one joint research project of Shanghai.